Nanotechnology in Antibacterial Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 438
Special Issue Editor
Interests: pulmonary drug delivery; bacteriophage therapy; biological antibacterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance has been recognized as one of the top global health threats. Facing the continuous challenges from “superbugs”, we are running out of effective antibiotics and stepping into the “post-antibiotic era”. This Special Issue, titled “Nanotechnology in Antibacterial Drug Delivery”, aims to explore the transformative role of nanotechnology in enhancing the efficacy and specificity of antibacterial therapies. It is critical to adopt innovative drug delivery systems that can optimize the therapeutic effectiveness while minimizing side effects of currently available antibiotics, as well as novel antibacterials. Nanotechnology offers novel solutions through the development of nanoparticle-based carriers that can improve drug solubility, stability, and targeted delivery to infection sites.
The significance of this research area is underscored by the urgent global health challenges posed by antibiotic resistance. By leveraging nanocarriers, such as liposomes, polymeric nanoparticles, and nanosuspensions, researchers can enhance drug penetration, facilitate controlled release, and promote synergistic effects with existing antibiogram therapies.
We invite original research articles and comprehensive reviews that investigate novel nanotechnology-based approaches to antibacterial drug delivery. Contributions addressing formulation strategies, targeting mechanisms, and the evaluation of therapeutic outcomes are particularly encouraged. Through this Special Issue, we aim to foster collaboration and knowledge exchange among researchers, ultimately advancing the development of effective antibacterial therapies that leverage the potential of nanotechnology.
I look forward to receiving your contributions.
Dr. Sharon Shui Yee Leung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug resistance
- antibiotic resistance
- multidrug-resistant bacteria
- antibiotics
- antibacterial therapies
- nanotechnology
- antibacterial drug delivery
- nanoparticles
- targeted delivery
- controlled release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
